![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/5-Figure2-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
![Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-017-2150-1/MediaObjects/345_2017_2150_Fig2_HTML.gif)
Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink
![Kaiser Permanente researchers develop new prostate cancer risk calculator - Kaiser Permanente Division of Research Kaiser Permanente researchers develop new prostate cancer risk calculator - Kaiser Permanente Division of Research](https://divisionofresearch.kaiserpermanente.org/wp-content/uploads/2020/07/Risk-Calc.jpg)
Kaiser Permanente researchers develop new prostate cancer risk calculator - Kaiser Permanente Division of Research
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283812008342-gr2.jpg)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov-2-FI.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor | Scientific Reports A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-43427-9/MediaObjects/41598_2019_43427_Fig1_HTML.png)
A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor | Scientific Reports
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1c.jpg)